Dear Partner, In 2018, I was privileged to be elected Chair of the Board of Directors of ANRF. One of our core functions at the Foundation is to select for funding, through a highly competitive review process, research proposals submitted by some of the brightest minds...
Dear valued Friend of ANRF, The challenges presented by Arthritis and associated Autoimmune Diseases are formidable and diverse. The Centers for Disease Control and Preventions (CDC) states that 25.9 % of the adult US population will be diagnosed with Arthritis by 2040. Arthritis is also the...
For nearly two decades, researchers have been scouring the human genome for genes that promote osteoarthritis (OA) in an effort to find new targets for osteoarthritis treatments. Today, scientists suspect that OA results not from unique genes, but from “epigenetic” changes in gene expression. Epigenetics...
Gale "Morrie" Granger (1937-2018), whose groundbreaking discoveries shaped modern therapeutic modalities in Arthritis, Immunology and Cancer, left us earlier this year at the age of 81. Morrie’s commitment to raising the next generation of thinkers was unparalleled, and his selfless dedication to ANRF remains our...
ANRF Scientific Advisory Board Chairman, Dr. Carl Ware and his team at Sanford Burnham Prebys Medical Discovery Institute (SBP), announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating LY3361237. LY3361237 is a biologic that inhibits inflammation by activating...
Challenging the Status Quo Dear valued Friend of ANRF, The challenges presented by Arthritis and associated Autoimmune Diseases are formidable and diverse. According to the Centers for Disease Control and Preventions (CDC), 25.9 % of the adult population in the US (or 78.4 million Americans, Graph) will...
Peter A. Nigrovic, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician at Brigham and Women’s Hospital. He is a practicing adult and pediatric rheumatologist and director of the Center for Adults with Pediatric Rheumatic Illness (CAPRI) at the Brigham and...
Dr. Nahle, ANRF Executive Director, participated in the two-day conference of Health Research Alliance (HRA), in Raleigh North Carolina. HRA is a collaborative member organization of non-profit research funders. It seeks to improve human health by maximizing the impact of biomedical research. At the 2018 meeting...
Held in Chicago, IL, the autumn Autoimmunology Conference 2018 was an opportunity for ANRF to foster one of their important objectives – the sponsorship and support of young innovative researchers. For more than four decades this conference has provided a collaborative platform that allows experienced...
Dr. Nahle, ANRF Executive Director, gave a series of invited medical lectures in the cities of Stockholm and Gothenburg, Sweden last October as part of a recent US and European presentation engagement. Meetings in Sweden were organized by RME, the largest Swedish Medical charity dedicated...